XIENCE™ Stent is the DES that delivers consistently outstanding short- and long-term patient outcomes.2
In fact, XIENCE™ Stent consistently has the lowest rate of late and very late stent thrombosis (ST)—not only a year but a decade after the intervention—providing evidence that the XIENCE™ Stent's unparalleled patient outcomes last far beyond the intervention.1
Long-term restenosis rates are also low, as shown by freedom from clinically driven target lesion revascularization (CD-TLR) at 7 years.9
XIENCE™ Stent has been shown to improve the quality of life of left main patients out to 3 years with 81% of patients reporting that they were angina free.
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?